Evaluation of Octreotide LAR in Prevention of Chemotherapy-induced Diarrhea

Clinical trial NCT00582426 · COMPLETED

Trial details

NCT number: NCT00582426
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Chemotherapy-induced Diarrhea

Start date: 2008-04-01
Primary completion: 2010-09-01
Enrollment: 139

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.